PCR 분자진단 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)

Global PCR Molecular Diagnostics Market size was valued at USD 8.2 billion in 2023 and is poised to grow from USD 8.67 billion in 2024 to USD 13.5 billion by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

The global PCR molecular diagnostics market is witnessing rapid growth, fueled by the increasing demand for accurate and timely diagnostic testing essential for identifying infectious diseases, genetic disorders, and cancer. PCR technology enhances diagnostic capabilities through the amplification and detection of specific DNA or RNA sequences, enabling personalized treatment approaches. However, challenges like high costs, complexity of techniques, and regulatory hurdles may hinder widespread adoption. Yet, advancements in PCR technology, including portable instruments and point-of-care devices, present significant opportunities for market expansion. Additionally, integrating PCR with next-generation sequencing and digital health platforms paves the way for multiplex testing and tailored therapies. Growing awareness of precision medicine further bolsters the market's potential to transform healthcare diagnostics and treatment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pcr Molecular Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global PCR Molecular Diagnostics Market Segmental Analysis

Global PCR Molecular Diagnostics Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Instrument, Reagents and Consumables and Software. Based on Application, the market is segmented into Infectious Disease Testing, Oncology Testing and Other Applications. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global PCR Molecular Diagnostics Market

One of the key drivers of the global PCR molecular diagnostics market is the rising emphasis on precision medicine. This innovative approach prioritizes the customization of medical treatments to suit individual patients' genetic profiles. By identifying specific genetic variations and biomarkers linked to various diseases, PCR molecular diagnostics facilitate the development of personalized treatment strategies. As healthcare systems increasingly embrace precision medicine methodologies, the demand for PCR molecular diagnostics is projected to grow significantly, enhancing the capability of healthcare providers to deliver tailored therapeutic interventions by the year 2022 and beyond.

Restraints in the Global PCR Molecular Diagnostics Market

One of the primary constraints facing the global PCR molecular diagnostics market is the substantial cost associated with testing. This financial burden can be particularly challenging in resource-constrained environments and areas with limited healthcare funding. The expenses related to the necessary equipment, reagents, and the recruitment of skilled personnel for conducting PCR tests contribute to accessibility issues, which are especially pronounced in developing nations. These cost limitations can hinder the broader adoption and implementation of PCR molecular diagnostics, posing significant challenges to achieving widespread testing and diagnosis in various regions, particularly in 2022.

Market Trends of the Global PCR Molecular Diagnostics Market

The global PCR molecular diagnostics market is experiencing a significant trend towards the integration of PCR technology with digital health platforms and telehealth solutions. This convergence enhances patient access to diagnostic services through remote test ordering and result reporting, improving overall efficiency in healthcare delivery. As healthcare providers leverage telehealth for real-time monitoring and data management, the ability to track disease outbreaks and streamline diagnostic workflows becomes more attainable. This trend not only fosters patient convenience but also optimizes resource allocation in clinical settings, positioning the global PCR market for substantial growth as the demand for innovative and accessible healthcare solutions continues to rise.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global PCR Molecular Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instrument
  • Standard PCR Systems
  • Digital PCR Systems
  • Real-time PCR Systems
• Reagents and Consumables
• Software

Global PCR Molecular Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Infectious Disease Testing
• Oncology Testing
• Other Applications

Global PCR Molecular Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Others

Global PCR Molecular Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN Manchester Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations